Post-Transplantation Diabetes Mellitus in Pediatric Patients
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
More than 80% of pediatric solid organ transplant (SOT) recipients now survive into young adulthood and many encounter transplant-related complications. Post-transplantation diabetes mellitus (PTDM), sometimes also referred to as post-transplant diabetes or new onset diabetes after transplant, occurs in 3-20% of pediatric SOT recipients depending upon the organ transplanted, age at transplantation, immunosuppressive regimen, family history, and time elapsed since transplant. To diagnose PTDM, hyperglycemia must persist beyond the initial hospitalization for transplantation when a patient is on stable doses of immunosuppressive medications. Though standard diagnostic criteria used by the American Diabetes Association (ADA) to diagnose diabetes are employed, clinicians need to be aware of the limitations of using these criteria in this unique patient population. Management of PTDM parallels strategies used for type 2 diabetes (T2D), while also carefully considering comorbidities and potential interactions with immunosuppressive medications in these patients. In caring for patients with PTDM, it is important to be familiar with these interactions and comorbidities in order to coordinate care with the transplant team and optimize outcomes for these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pretransplant elevation in hs-CRP was associated with PTDM in the setting of renal transplant (150,151).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [150]
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Diabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes
Moran, A., Brunzell, C., Cohen, R. C., Katz, M., Marshall, B. C., Onady, G., Robinson, K. A., Sabadosa, K. A., Stecenko, A., Slovis, B., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1768 · Cited by 726
Metformin in Patients With Type 2 Diabetes and Kidney Disease: A Systematic Review
Inzucchi, S. E., Lipska, K. J., Mayo, H., Bailey, C. J., & McGuire, D. K. (2014) · JAMA · doi:10.1001/jama.2014.15298 · Cited by 601
Webster, A. C., Woodroffe, R. C., Taylor, R. S., Chapman, J. R., & Craig, J. C. (2005) · BMJ · doi:10.1136/bmj.38569.471007.ae · Cited by 587
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
Woodle, E. S., First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., & Van Veldhuisen, P. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318187d1da · Cited by 474
Cosio, F. G., Kudva, Y., van der Velde, M., Larson, T. S., Textor, S. C., Griffin, M. D., & Stegall, M. D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00349.x · Cited by 394
Simental‐Mendía, L. E., Sahebkar, A., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.019 · Cited by 362
Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
Johnston, O., Rose, C. L., Webster, A. C., & Gill, J. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111202 · Cited by 359
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“Pretransplant elevation in hsCRP was associated with PTDM in the setting of renal transplant (156,157).”
Background2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
Pediatric Liver Transplantation: Long-Term Follow-Up Issues
Bellini, M. I., Lauro, A., D’Andrea, V., & Marino, I. R. (2022) · Experimental and Clinical Transplantation · doi:10.6002/ect.pediatricsymp2022.l16 · Cited by 8
“56”
Calvo-Herrera, M. A., Serna-Campuzano, A. M., López, M. C. I., Villegas-Arbeláez, E., Rojas-Rosas, L. F., Serna-Higuita, L. M., & Ochoa-García, C. L. (2024) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2024-002710 · Cited by 3
Dong, Y. (2023) · Investigación Clínica · doi:10.54817/ic.v64n4a03 · Cited by 2
“PTDM, with an incidence of about 4-25%, usually occurs within one year after surgery 4 .”
Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus
Mei, S. C. S., Pritchard, N., Grayton, H. M., Simonicova, I., Park, S. M., & Adler, A. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0133 · Cited by 3
“Some immunosuppressive agents increase insulin resistance and cause insulin deficiency ( 10).”
BackgroundEndocrine complications after solid organ transplantation in childhood and adolescents
Yoon, J., Kim, D., Hwang, S., Kim, J. H., & Choi, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1658780 · Cited by 3
Post-Transplantations-Diabetes mellitus: Häufige Komplikation nach Transplantation
Ott, U. (2023) · Nephrologie aktuell · doi:10.1055/a-2055-3728
“Ein aktiver Lebensstil reduziert das Risiko für einen PTDM [34].”
BackgroundInfluentialNutritional Management of Children with Kidney Disease
(2025) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610027700-ch36
Salonen, R., Endén, K., Koskela, M., Jahnukainen, K., Nikkilä, A., & Jahnukainen, T. (2025) · Clinical Transplantation · doi:10.1111/ctr.70256
“Earlier studies have indicated that 3%–20% of the pediatric SOT patients develop new-onset diabetes [22–24].”
New onset diabetes after kidney transplantation: impact of tacrolimus cessation on outcomes
Sullivan, K. M., Kilduff, S. R., Becerril‐Romero, C., Matossian, D., Khanna, P., Thomas, B. S., & Verghese, P. S. (2026) · Research Connections · doi:10.1093/rescon/vmag098
Metadata
- Authors
- Grundman, J. B., Wolfsdorf, J. I., & Marks, B. E.
- Affiliations
- Children's National (US)
- Boston Children's Hospital (US)
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 93
- Issue
- 9-10
- Pages
- 510-518
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W3147547879
- Cited by
- 12
- References
- 56
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 1
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- post-transplant diabetes mellitus, pediatric solid organ transplantation, immunosuppressants, drug interactions, diabetes diagnosis, type 2 diabetes management, comorbidities, hyperglycemia, transplant complications
- MeSH terms
- Child, Diabetes Mellitus, Humans, Immunosuppressive Agents, Postoperative Complications, Organ Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.